RESEARCH TRIANGLE PARK, N.C., U.S.A. (June 21, 2004)

  Qualyst, Inc., a privately held biotechnology company, announced today the hiring of Marc Sedam as Vice President for Corporate Development and Dr. Robert St. Claire as Director of Chemistry.

  “The addition of Marc and Bob will allow Qualyst to continue its high level of customer support and innovation to the life sciences industry," said Scott Neuville, President and CEO of Qualyst.

  Mr. Sedam, previously Associate Director for the Office of Technology Development at the University of North Carolina at Chapel Hill, will be responsible for intellectual property management and licensing.  “I have worked within UNC on the business idea that grew into Qualyst since 1998,” said Sedam.  “The combination of Qualyst’s innovative technology, its existing team and the opportunity to join and help grow this dynamic company made this the right time for a return to the industry.”

  Dr. St. Claire has 18 years of experience in the fields of bioanalytical and analytical chemistry within the pharmaceutical industry. As a senior technical leader at Glaxo, Glaxo Wellcome, Triangle Pharmaceuticals and most recently at Gilead Sciences, his primary focus has been in novel technology, methods development and teaching.  “The most exciting aspect of Qualyst is the opportunity to contribute to the development of ADMET technologies with utility across all therapeutic areas,” said Dr. St. Claire.

About Qualyst, Inc.
Qualyst commercializes novel and proprietary ADMET products for drug discovery and development. Qualystís products allow pharmaceutical and biotechnology researchers to make faster, better decisions regarding drug candidate compounds, saving valuable time and research dollars in the process. Qualyst, Inc. was founded on discoveries from breakthrough research at the University of North Carolina at Chapel Hill in 2001. For additional information, please refer to the company's web site at www.Qualyst.com or call 919-313-6500.

CONTACT:

Ian J. Mehr
Vice President, Business Development
Qualyst, Inc.
919-313-6507
info[AT]qualyst[DOT]com
www.Qualyst.com